Lewis R. Roberts
Hepatology · 2006–2020
A researcher in the Science corpus: 16 papers; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hepatology — 186 citations into it
- Epidemiology — 133 citations into it
- Oncology — 104 citations into it
Whom Lewis R. Roberts trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Lewis R. Roberts's perspective
Ordered by how strongly the researchers Lewis R. Roberts trusts endorse each paper. Same corpus, a different order for every researcher.
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. (The Lancet Oncology)
- Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
- Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. (Gastroenterology)
- Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. (American Journal of Epidemiology)
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study (Cardiovascular and Interventional Radiology)
- Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling (Hepatology)
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival (Hepatology)
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells (Nature Medicine)
- Non-Alcoholic Fatty Liver Disease and Hepatocellular Cancer: A Systematic Review (Clinical Gastroenterology and Hepatology)
- Primary liver cancer: worldwide incidence and trends. (Gastroenterology)
Their papers
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells (2006) — 937 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (2017) — 2,216 citations
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management (2020) — 2,046 citations
- A global view of hepatocellular carcinoma: trends, risk, prevention and management (2019) — 3,633 citations
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases (2019) — 3,139 citations
- AASLD guidelines for the treatment of hepatocellular carcinoma (2018) — 3,751 citations
- Pathogenic germline variants in 10,389 adult cancers (2018) — 734 citations
- The Immune Landscape of Cancer (2018) — 4,752 citations
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. (2018) — 1,437 citations
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) — 2,663 citations
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. (2017) — 1,848 citations
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015) — 1,194 citations
- Hepatocellular carcinoma: a global view (2010) — 1,309 citations
- Epidemiology and Management of Hepatocellular Carcinoma (2010) — 623 citations